4.2.2. 4,4,4-trifluoro-2-(2-methoxyphenyl)butan-2-yl 2-iodobenzoate (3b)
Colorless oil; 86.8 mg, 93%; 1H NMR (400 MHz, CDCl3): δ = 2.12 (s, 3H), 3.38–3.50 (m, 2H),
3.85 (s, 3H), 6.94 (d, J = 8.3 Hz, 1H), 7.00 (ddd, J = 1.4, 7.6, 8.3 Hz, 1H), 7.17 (ddd, J = 1.4, 7.8,
7.8 Hz, 1H), 7.31 (m, 1H), 7.45 (ddd, J = 0.9, 7.8, 7.8 Hz, 1H), 7.53 (dd, J = 1.4, 7.8 Hz, 1H), 7.87
(dd, J = 1.4, 7.8 Hz, 1H), 8.00 (dd, J = 0.9, 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 25.0,
40.4 (q, J = 27.0 Hz), 55.2, 81.7 (q, J = 2.9 Hz), 93.8, 111.4, 120.7, 125.6 (q, J = 278.4 Hz), 126.5,
127.9, 129.1, 129.6, 130.7, 132.3, 136.0, 141.1, 155.5, 164.9; 19F NMR (376 MHz, CDCl3): δ =
–60.4 (t, J = 10.4 Hz); IR (neat): 2939, 1721, 1581, 1439, 1387, 1368, 1316 cm-1; HRMS (ESI+):
Calcd. for [C18H16F3IO3+Na]+: m/z = 486.9994, Found: 486.9992.
4.2.3. 4,4,4-trifluoro-2-(naphthalen-2-yl)butan-2-yl 2-iodobenzoate (3c)
Colorless oil; 78.3 mg, 81%; 1H NMR (400 MHz, CDCl3): δ = 2.25 (s, 3H), 3.09–3.21 (m, 1H),
3.29-3.41 (m, 1H), 7.18 (ddd, J = 1.8, 7.8, 7.8 Hz, 1H), 7.44–7.59 (m, 4H), 7.84–7.93 (m, 5H),
8.02 (dd, J = 0.9, 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 25.7, 44.0 (q, J = 27.0 Hz), 81.5
(q, J = 1.9 Hz), 93.9, 122.2, 123.4, 125.3 (q, J = 278.4 Hz), 126.3, 126.4, 127.5, 128.0, 128.3,
128.6, 130.9, 132.6, 133.0, 135.5, 140.3, 141.3, 164.8; 19F NMR (376 MHz, CDCl3): δ = –59.8 (t,
J = 10.4 Hz); IR (neat): 3059, 1731, 1583, 1508, 1464, 1430, 1198 cm-1; HRMS (ESI+): Calcd. for
[C21H16F3IO2+Na]+: m/z = 507.0045, Found: 507.0040.
4.2.4. 2-(3-bromophenyl)-4,4,4-trifluorobutan-2-yl 2-iodobenzoate (3d)
Colorless oil; 11.1 mg, 11%; 1H NMR (400 MHz, CDCl3): δ = 2.10 (s, 3 H), 2.96–3.21 (m, 2H),
7.18 (ddd, J = 1.8, 7.8, 7.8 Hz, 1H), 7.24–7.28 (m, 1H), 7.37 (ddd, J = 1.8, 1.8, 7.8 Hz, 1H),
7.42–7.46 (m, 2H), 7.59 (dd, J = 1.8, 1.8 Hz, 1H), 7.81 (dd, J = 1.8, 7.8 Hz, 1H), .8.00 (dd, J = 0.9,
7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 25.6, 44.0 (q, J = 27.0 Hz), 80.7, 93.8, 122.9, 123.1,
125.0 (q, J = 278.4 Hz), 127.0, 128.1, 130.2, 130.8, 131.0, 132.8, 135.3, 141.4, 145.3, 164.8: 19F
NMR (376 MHz, CDCl3): δ = –59.9 (t, J = 10.4 Hz). IR (neat): 2920, 1731, 1582, 1567, 1464,
1419, 1371, 1192 cm-1; HRMS (EI+): Calcd. for [C17H13BrF3IO2]+: m/z = 511.9096, Found:
511.9088.
4.2.5. 1-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydronaphthalen-1-yl 2-iodobenzoate (3e)
Colorless oil; 42.0 mg, 46%; 1H NMR (400 MHz, CDCl3): δ = 1.84–1.95 (m, 1H), 2.10–2.18 (m,
1H), 2.43–2.47 (m, 1H), 2.81–3.21 (m, 5H), 7.12–7.16 (m, 2H), 7.20–7.22 (m, 2H), 7.41 (dd, J =
7.8, 7.8 Hz, 1H), 7.46–7.48 (m, 1H), 7.81 (d, J = 7.8 Hz, 1H), 7.97 (d, J = 7.8 Hz, 1H); 13C NMR
(100 MHz, CDCl3): δ = 20.2, 29.1, 30.5, 44.0 (q, J = 27.0 Hz), 81.2 (br), 93.8, 125.2 (q, J = 278.4
Hz), 125.5, 126.4, 127.9, 128.0, 129.3, 130.7, 132.5, 135.7, 136.7, 137.3, 141.3, 164.5; 19F NMR
(376 MHz, CDCl3): δ = –59.3 (t, J = 10.4 Hz); IR (neat): 2940, 1730, 1582, 1490, 1463, 1429,
Page 12 of 21